New York

With a network of international and domestic offices, WilmerHale has built a reputation as a global powerhouse. Nationally, the firm’s original mainstay in Boston continues to secure near-unanimous recognition in litigation, and the New York, DC and California offices have further bolstered the firm’s top-tier standing. It is lauded for its litigation capabilities nationwide, particularly antitrust, white-collar, securities and appellate, as well as intellectual property, one of the firm’s most notable practices.

Boston-based trial lawyer Bill Lee is of the most accomplished litigators in intellectual property. He continues to add to his enviable list of milestone patent wins, which have earned him a long-standing reputation in the practice area. In these high-stakes cases, he is well known for his distinguishing ability to translate his encyclopedic knowledge into comprehensive arguments that sway judges and juries. Lee and Denver’s Mary “Mindy” Sooter obtained a damages-less win for Comcast in a patent infringement lawsuit brought by NextStep. Last September in Delaware, the federal jury found in favor of the client on two of the challenged patents, and returned a “doctrine of equivalents” infringement verdict on the last patent. Sooter and Lee secured the zero-dollar victory with a granted motion to preclude the plaintiff’s damages case.

In the appellate arena, Lee also obtained positive results working with appellate expert Seth Waxman of the DC office. The duo represented Abbott Laboratories and AbbVie against the Federal Trade Commission (FTC) before the Court of Appeals for the Third Circuit. The FTC filed a case alleging that the lawsuits filed by AbbVie against Teva and Perrigo were shams, thus violating the FTC Act. The District Court granted summary judgment in favor of the FTC, which AbbVie appealed. The Third Circuit in parts affirmed, reversed, and vacated the District Court’s decision. Notably, the appellate court held that its lawsuit against Teva was not a sham, and the court vacated the disgorgement award. On the Perrigo matter, the Third Circuit upheld the District Court decision that the suit was objectively baseless, which Lee and Waxman challenged in a petition for certiorari that was denied. However, in a complete victory, the FTC dropped the entire case.

Waxman serves as chair of the firm’s appellate and Supreme Court litigation practice, with, as one peer notes, “an army of talent behind him”. Such talent includes Noah Levine, who represented the Federal National Mortgage Association (Fannie Mae) in a putative class action challenging non-judicial foreclosures in Rhode Island, arguing that the client and co-defendant violated the Due Process Clause as plaintiffs also argued that the defendants should be considered government actors. The District Court rejected both arguments, dismissing the complaints. On appeal, the First Circuit upheld the decision, securing a win for the client.

In New York, commercial litigator Hallie Levin obtained a win for T-Mobile in a five-day bench trial before the Delaware Court of Chancery. The trial arose from a settlement agreement between T-Mobile and Cox Communications that concluded a patent infringement case. In the agreement, Cox agreed that should it begin offering retail customers wireless services, it would be done in accordance with a wholesale wireless agreement with Sprint, which T-Mobile acquired. Cox and another mobile network later entered into a wholesale wireless agreement, and sued the client last January, arguing that the provision was unenforceable. Acting on behalf of T-Mobile, Levin filed counterclaims and requested an injunction to enforce the exclusivity obligation. The District Court found that Cox had breached the agreement and the provision was enforceable. The court issued an injunction preventing Cox from offering mobile services with any other operator.

On the West Coast, Sonal Mehta is continuously recognized as a top-tier litigator in the IP space, especially for her role representing titans of the life sciences and technology industry. Recently, she represented Ionpath, a venture-backed start-up by three Stanford professors who sought to commercialize their technology for biological tissue analysis, against competitor Fluidigm. The Northern District of California, in an accelerated patent “showdown” procedure, ruled Ionpath did not infringe the “showdown” claims. After the decision, Fluidigm dismissed its interference with contract claims, and later the plaintiff dismissed the rest of the claims in its appeal. The matter closed confidentially.